Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Document preview thumbnail
Vista previa 4 fuera de 91 páginas
Examen

NR 565 Advanced Pharmacology Week 1 Quiz - 200 Verified Q&A (2026 Edition)

Document preview thumbnail
Vista previa 4 fuera de 91 páginas

Get ahead in NR 565 Advanced Pharmacology with this comprehensive Week 1 Quiz exam preparation document containing 200 verified questions and answers updated for the 2026/2027 academic year. This meticulously crafted resource mirrors the actual exam style and includes detailed rationales for every answer, explaining both correct responses and why distractors are incorrect. Perfect for self-paced study and mastery of essential pharmacological principles. What's Inside: Pharmacokinetics & Pharmacodynamics (Absorption, Distribution, Metabolism, Excretion, Receptor Theory) Drug Classification & Mechanisms of Action (Antibiotics, Analgesics, Cardiovascular Drugs, CNS Agents) Prescribing Principles & Legal/Ethical Considerations (Prescription Writing, DEA Regulations, Off-Label Use) Patient Education & Safety Monitoring (Adverse Effects, Drug Interactions, Monitoring Parameters) Special Populations (Pediatric, Geriatric, Pregnancy, Renal/Hepatic Impairment) Updated for 2026: Latest FDA-approved medications New telehealth prescribing considerations Updated safety alerts and black box warnings Evidence-based rationales Why This Document Works: 200 exam-style questions with comprehensive rationales Content aligned with 2026/2027 NR 565 course objectives Covers ALL Week 1 required topics Verified for accuracy by pharmacology experts Reinforces conceptual understanding and clinical application Ideal for nursing students aiming to excel in pharmacology coursework and clinical practice. Graded A+ by previous students

Vista previa del contenido

NUR 265 Advanced Nursing Concepts, Patient Care, and
Clinical Decision-Making Assessment & Medical-Surgical
Nursing - Exams 1, 2, 3, Midterm & Final Ultimate Bundle |
2026/2027 Edition | 200 Verified Questions
NUR 265 Midterm & Final Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100%
Verified Solutions | Updated Per Latest Guidelines | Graded A+

This comprehensive exam prep bundle for NUR 265 covers all major assessments across the academic
year, including Exams 1, 2, 3, the midterm, and the final. It features 200 verified questions that reflect
the latest NCLEX-style formats and current medical-surgical nursing guidelines. Each question is
accompanied by detailed rationales and evidence-based explanations to reinforce advanced nursing
concepts and clinical decision-making. Ideal for nursing students seeking a high-yield, exam-focused
review that ensures readiness for high-stakes testing.


Key Features:
Advanced patient assessment and clinical reasoning
Medical-surgical nursing management of complex conditions
Pharmacological and non-pharmacological interventions
Priority setting and delegation in acute care
Evidence-based practice and quality improvement
Exam-specific question sets with rationales
Updates for 2026:
- Updated to reflect 2026-2027 NCLEX-RN test plan changes
- Revised rationales to align with latest clinical practice guidelines
- Added new questions on emerging healthcare trends and technologies
- Enhanced explanations for critical thinking and prioritization
- Reorganized content to match current NUR 265 course objectives
Abstract:
The NUR 265 Advanced Nursing Concepts, Patient Care, and Clinical Decision-Making Assessment &
Medical-Surgical Nursing bundle is a meticulously curated resource designed for nursing students preparing for
comprehensive examinations. This edition encompasses 200 verified questions distributed across Exams 1, 2, 3, the
midterm, and the final, covering a broad spectrum of medical-surgical nursing topics. The content emphasizes
advanced pathophysiological concepts, evidence-based interventions, and clinical judgment frameworks essential
for safe and effective patient care. Each question is crafted to mirror the rigor of licensure examinations, with
detailed rationales that dissect correct and incorrect options, thereby fostering deeper understanding. The bundle
also integrates current guidelines and best practices, ensuring alignment with contemporary healthcare standards.
By systematically addressing key areas such as cardiovascular, respiratory, neurological, and renal disorders, this
resource serves as an indispensable tool for achieving academic excellence and clinical competence.
Keywords:
NUR 265, Medical-Surgical Nursing, Clinical Decision-Making, Advanced Nursing Concepts, Exam Prep,
NCLEX-style Questions, Patient Care, Nursing Rationales
Answer Format:
Each question is presented in NCLEX-style format with multiple-choice, select-all-that-apply, and
ordered-response items. Answers are provided with a clear correct option, followed by a comprehensive rationale




Page 1

,explaining the underlying pathophysiology and clinical reasoning. Incorrect options are also analyzed to highlight
common misconceptions and distractors, ensuring a thorough learning experience.
Compliance Checklist:
Aligned with 2026-2027 NCLEX-RN test plan
Reflects current AACN and QSEN competencies
Incorporates evidence-based practice guidelines
Includes rationales for all correct and incorrect answers
Verified for accuracy by subject matter experts
Updated to reflect latest medical-surgical nursing standards
Content Area Overview:

Content Area Questions Key Topics Weight

Cardiovascular & Hematologic 1-40 Heart failure, MI, arrhythmias, DVT, 20%
Disorders anemia, coagulopathies
Respiratory & ENT Disorders 41-80 COPD, asthma, pneumonia, ARDS, 20%
pulmonary embolism, tracheostomy care
Neurological & Sensory 81-120 Stroke, seizures, increased ICP, meningitis, 20%
Disorders glaucoma, hearing loss
Renal, Hepatic, & 121-160 AKI, CKD, cirrhosis, hepatitis, pancreatitis, 20%
Gastrointestinal Disorders GI bleed, ostomy care
Endocrine, Immune, & 161-200 Diabetes, thyroid disorders, HIV/AIDS, 20%
Integumentary Disorders sepsis, burns, wound care




Page 2

,Q1. A patient with acute decompensated heart failure and rapid atrial fibrillation is
receiving continuous IV nesiritide. Which assessment finding requires immediate
intervention?
A. Systolic blood pressure of 88/60 mm Hg
B. Heart rate of 118 beats per minute
C. Urine output of 30 mL over the past hour
D. Serum potassium of 3.8 mEq/L
Correct Answer: A. Systolic blood pressure of 88/60 mm Hg
Rationale: Nesiritide (B-type natriuretic peptide) causes vasodilation and can precipitate
severe hypotension. A systolic BP of 88/60 indicates significant hypotension, which can
compromise organ perfusion and requires immediate dose reduction or discontinuation.
The other findings are expected or less urgent in this context.
Why Wrong:
B - Tachycardia is common in rapid AF and may improve with rate control, but it is
not the immediate life-threatening issue.
C - Urine output of 30 mL/hr is low but not as immediately critical as hypotension; it
may reflect renal hypoperfusion secondary to low BP.
D - Potassium of 3.8 mEq/L is within normal limits and not a cause for immediate
intervention.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 24 (Heart
Failure)

Q2. In a patient with septic shock and persistent hypotension despite fluid
resuscitation, which vasopressor is recommended as first-line therapy per the
Surviving Sepsis Campaign?
A. Dopamine
B. Norepinephrine
C. Epinephrine
D. Vasopressin
Correct Answer: B. Norepinephrine
Rationale: Current guidelines recommend norepinephrine as the first-line vasopressor for
septic shock due to its alpha-adrenergic potency and favorable safety profile. Dopamine
has fallen out of favor due to increased arrhythmia risk. Epinephrine and vasopressin are
reserved for refractory shock or as adjuncts.
Why Wrong:
A - Dopamine is no longer preferred due to higher risk of tachyarrhythmias and lack
of mortality benefit.
C - Epinephrine is a second-line agent, often added when norepinephrine fails to
achieve target MAP.




Page 3

, D - Vasopressin is an adjunctive agent, not first-line, typically added to reduce
norepinephrine requirements.
Reference: Evans, L. et al. (2021). Surviving Sepsis Campaign: International Guidelines
for Management of Sepsis and Septic Shock 2021. Critical Care Medicine.

Q3. A patient on a heparin drip for pulmonary embolism develops a sudden drop in
platelet count from 180,000 to 90,000/µL. Which action is most appropriate?
A. Continue heparin and monitor platelet count daily
B. Switch to enoxaparin and recheck platelets in 24 hours
C. Discontinue all heparin products and start a direct thrombin inhibitor
D. Administer platelet transfusion to correct thrombocytopenia
Correct Answer: C. Discontinue all heparin products and start a direct thrombin
inhibitor
Rationale: The drop in platelets suggests heparin-induced thrombocytopenia (HIT), a
life-threatening immune-mediated reaction. All heparin products must be stopped
immediately, and alternative anticoagulation with a direct thrombin inhibitor (e.g.,
argatroban) is required to prevent thrombosis. Platelet transfusions are contraindicated in
HIT.
Why Wrong:
A - Continuing heparin would worsen HIT and increase the risk of thrombosis.
B - Enoxaparin is a heparin product and is contraindicated in HIT.
D - Platelet transfusions are avoided in HIT as they can precipitate thrombotic events.
Reference: Warkentin, T.E. (2015). Heparin-Induced Thrombocytopenia. New England
Journal of Medicine.

Q4. questionType: table
A. All anticipated
B. Mixed responses
C. All nonessential
D. All contraindicated
Correct Answer: B. Mixed responses
Rationale: In DKA, potassium shifts intracellularly with insulin, so replacement is needed
when serum K+ drops below 5.0 mEq/L (anticipated). An immediate second insulin bolus
is contraindicated because it could cause severe hypokalemia and hypoglycemia.
Bicarbonate is nonessential for pH >7.0; it is reserved for pH <6.9. Hourly glucose
monitoring and transitioning to subcutaneous insulin after anion gap closure are
standard.
Why Wrong:
A - Not all are anticipated; the second insulin bolus is contraindicated.




Page 4

Información del documento

Subido en
5 de agosto de 2026
Número de páginas
91
Escrito en
2026/2027
Tipo
Examen
Contiene
Preguntas y respuestas
$26.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
Studymart
4.8
(346)
Vendido
95
Seguidores
63
Artículos
1354
Última venta
1 semana hace


Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes